These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

850 related articles for article (PubMed ID: 27468191)

  • 1. Pancreatic cancer stem cell markers and exosomes - the incentive push.
    Heiler S; Wang Z; Zöller M
    World J Gastroenterol; 2016 Jul; 22(26):5971-6007. PubMed ID: 27468191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic cancer-initiating cell exosome message transfer into noncancer-initiating cells: the importance of CD44v6 in reprogramming.
    Wang Z; Sun H; Provaznik J; Hackert T; Zöller M
    J Exp Clin Cancer Res; 2019 Mar; 38(1):132. PubMed ID: 30890157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tetraspanins CD151 and Tspan8 are essential exosome components for the crosstalk between cancer initiating cells and their surrounding.
    Yue S; Mu W; Erb U; Zöller M
    Oncotarget; 2015 Feb; 6(4):2366-84. PubMed ID: 25544774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD44v6-competent tumor exosomes promote motility, invasion and cancer-initiating cell marker expression in pancreatic and colorectal cancer cells.
    Wang Z; von Au A; Schnölzer M; Hackert T; Zöller M
    Oncotarget; 2016 Aug; 7(34):55409-55436. PubMed ID: 27419629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Claudin7-dependent exosome-promoted reprogramming of nonmetastasizing tumor cells.
    Kyuno D; Zhao K; Schnölzer M; Provaznik J; Hackert T; Zöller M
    Int J Cancer; 2019 Oct; 145(8):2182-2200. PubMed ID: 30945750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exosomes, metastases, and the miracle of cancer stem cell markers.
    Wang Z; Zöller M
    Cancer Metastasis Rev; 2019 Jun; 38(1-2):259-295. PubMed ID: 31030373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined evaluation of a panel of protein and miRNA serum-exosome biomarkers for pancreatic cancer diagnosis increases sensitivity and specificity.
    Madhavan B; Yue S; Galli U; Rana S; Gross W; Müller M; Giese NA; Kalthoff H; Becker T; Büchler MW; Zöller M
    Int J Cancer; 2015 Jun; 136(11):2616-27. PubMed ID: 25388097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tspan8, CD44v6 and alpha6beta4 are biomarkers of migrating pancreatic cancer-initiating cells.
    Wang H; Rana S; Giese N; Büchler MW; Zöller M
    Int J Cancer; 2013 Jul; 133(2):416-26. PubMed ID: 23338841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p.
    Wang L; Yang G; Zhao D; Wang J; Bai Y; Peng Q; Wang H; Fang R; Chen G; Wang Z; Wang K; Li G; Yang Y; Wang Z; Guo P; Peng L; Hou D; Xu W
    Mol Cancer; 2019 Apr; 18(1):86. PubMed ID: 30975145
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas.
    Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T
    Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer.
    Giovannetti E; van der Borden CL; Frampton AE; Ali A; Firuzi O; Peters GJ
    Semin Cancer Biol; 2017 Jun; 44():43-59. PubMed ID: 28438662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of NR5A2 inhibition on pancreatic cancer stem cell (CSC) properties and epithelial-mesenchymal transition (EMT) markers.
    Luo Z; Li Y; Zuo M; Liu C; Tian W; Yan D; Wang H; Li D
    Mol Carcinog; 2017 May; 56(5):1438-1448. PubMed ID: 27996162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD44 and EpCAM: cancer-initiating cell markers.
    Marhaba R; Klingbeil P; Nuebel T; Nazarenko I; Buechler MW; Zoeller M
    Curr Mol Med; 2008 Dec; 8(8):784-804. PubMed ID: 19075676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomolecular characterization of exosomes released from cancer stem cells: Possible implications for biomarker and treatment of cancer.
    Kumar D; Gupta D; Shankar S; Srivastava RK
    Oncotarget; 2015 Feb; 6(5):3280-91. PubMed ID: 25682864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.
    Suresh R; Ali S; Ahmad A; Philip PA; Sarkar FH
    Adv Exp Med Biol; 2016; 890():57-74. PubMed ID: 26703799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ping-Pong-Tumor and Host in Pancreatic Cancer Progression.
    Mu W; Wang Z; Zöller M
    Front Oncol; 2019; 9():1359. PubMed ID: 31921628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes from bulk and stem cells from human prostate cancer have a differential microRNA content that contributes cooperatively over local and pre-metastatic niche.
    Sánchez CA; Andahur EI; Valenzuela R; Castellón EA; Fullá JA; Ramos CG; Triviño JC
    Oncotarget; 2016 Jan; 7(4):3993-4008. PubMed ID: 26675257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
    Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA-200c overexpression plays an inhibitory role in human pancreatic cancer stem cells by regulating epithelial-mesenchymal transition.
    Ma C; Ding YC; Yu W; Wang Q; Meng B; Huang T
    Minerva Med; 2015 Aug; 106(4):193-202. PubMed ID: 26081037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic cancer stem cells: A state or an entity?
    Hermann PC; Sainz B
    Semin Cancer Biol; 2018 Dec; 53():223-231. PubMed ID: 30130664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.